CMF8 Molecular Imaging and Radionuclide Therapy of Functional Neuroendocrine Tumours

Program: Case Management Forums
Clinical Session
Sunday, April 3, 2016: 3:30 PM-4:15 PM
Room 205 (BCEC)
David A Pattison, MBBS, MPH, FRACP, FAANMS, Peter MacCallum Cancer Centre, East Melbourne, Australia and Thomas M O'Dorisio, MD, University of Iowa, Iowa City, IA

Nothing to Disclose: DAP, TMO
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire